(Reuters) – Novo Nordisk’s chief executive is preparing for a showdown next week with U.S. Senator Bernie Sanders over the high price of blockbuster diabetes and weight loss drugs, as Ozempic falls into the scope of U.S. government price controls, the
(Reuters) – Novo Nordisk’s chief executive is preparing for a showdown next week with U.S. Senator Bernie Sanders over the high price of blockbuster diabetes and weight loss drugs, as Ozempic falls into the scope of U.S. government price controls, the Financial Times reported on Monday.
(Reporting by Disha Mishra in Bengaluru; Editing by Christopher Cushing)
A blockbuster drug is a pharmaceutical product that generates annual sales of over $1 billion. These drugs are often widely prescribed and have significant market impact.
A congressional hearing is a formal meeting held by a legislative body to gather information, discuss issues, and hold inquiries. It often involves testimonies from experts and stakeholders.
Explore more articles in the Top Stories category
